Clinical Trial Update: Study for Assessing the Prevalence of Airflow Limitation in Outpatients With History of Smoking Attending Cardiology Clinics

View source ↗

Summary

An AstraZeneca-sponsored clinical trial to determine the prevalence of airflow limitation among outpatients with a history of smoking attending cardiology clini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: Respiratory (Chronic Obstructive Pulmonary Disease) | Status: RECRUITING